CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank75
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-22.36M
↑ 62% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-59.64M
Historical baseline
PeriodValueYoY Change
TTM$-22.36M-189.5%
2024$25.00M+485.5%
2023$-6.48M+93.6%
2022$-101.33M+12.7%
2021$-116.04M-44.1%
2020$-80.54M+27.4%
2019$-110.89M-42.4%
2018$-77.87M-68.3%
2017$-46.26M+22.4%
2016$-59.59M-